A carregar...
AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Steroid hormones and bile acids are potent regulators of hepatic carbohydrate and lipid metabolism. Steroid 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid h...
Na minha lista:
| Publicado no: | Metabolism |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
W.B. Saunders
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6744372/ https://ncbi.nlm.nih.gov/pubmed/31330134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2019.153947 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|